U.S. Markets open in 6 hrs 9 mins

PURE Bioscience, Inc. (PURE)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.18+0.03 (+2.61%)
At close: 3:26PM EDT
People also watch
Full screen
Previous Close1.15
Bid0.00 x
Ask0.00 x
Day's Range0.00 - 0.00
52 Week Range
Avg. Volume63,015
Market Cap73.99M
PE Ratio (TTM)-14.39
EPS (TTM)-0.08
Earnings DateJun 9, 2017 - Jun 12, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Zacks Small Cap Research14 days ago

    PURE: Update on Fiscal Third Quarter Financials

    Total revenues for the fiscal third quarter ended April 30, 2017 were $338,000, compared with revenues of $403,000 in the prior year fiscal third quarter ended 2016, a decrease of 16%. Last year’s order was placed in the third quarter of FY 2016, and this year’s order was received in the first week of the fourth fiscal quarter in 2017. Gross margin was 61% during the third quarter of fiscal 2017 as compared with 71% during the same period in fiscal 2016 due to product mix.

  • Thomson Reuters StreetEvents17 days ago

    Edited Transcript of PURE earnings conference call or presentation 8-Jun-17 8:30pm GMT

    Q3 2017 PURE Biosciences Inc Earnings Call

  • PURE Bioscience, Inc. :PURE-US: Earnings Analysis: Q3, 2017 By the Numbers : June 9, 2017
    Capital Cube18 days ago

    PURE Bioscience, Inc. :PURE-US: Earnings Analysis: Q3, 2017 By the Numbers : June 9, 2017

    Categories: Yahoo FinanceGet free summary analysis PURE Bioscience, Inc. reports financial results for the quarter ended April 30, 2017. We analyze the earnings along side the following peers of PURE Bioscience, Inc. – Calgon Carbon Corporation, Ecolab Inc., Ocean Bio-Chem, Inc. and United-Guardian, Inc. (CCC-US, ECL-US, OBCI-US and UG-US) that have also reported for this period. Highlights ... Read more (Read more...)